MedinCell believes that the best way to maximise our common strategy  is to start with a low cost initial study, that may then proceed to a full collaborative project on the  basis of several go/no-go decision steps.

MedinCell has, for that reason, designed an efficient, collaborative plan (i.e., co-development), easy to deal with, which includes three technological levels of exploration :

- Decision support :
to quickly evaluate the potentiality of the candidate molecule, using the 141™ (1 week for 1 answer) and 441™ (4 weeks for 1 test) tools, and to decide whether to go head with the feasibility studies.

- Feasibility studies :
to start the co-development, find the optimal polymer, determine the preclinical profiles, design the development and regulatory strategies.